BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21589878)

  • 21. CD40-CD40 ligand signal induces the intercellular adhesion molecule-1 expression through nuclear factor-kappa B p50 in cultured salivary gland epithelial cells from patients with Sjögren's syndrome.
    Saito M; Ota Y; Ohashi H; Dei Y; Shimoyama K; Suzuki D; Hayashi H; Ogawa N
    Mod Rheumatol; 2007; 17(1):45-53. PubMed ID: 17278022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indicators of salivary gland inflammation in primary Sjogren's syndrome.
    Cuida M; Halse AK; Johannessen AC; Tynning T; Jonsson R
    Eur J Oral Sci; 1997 Jun; 105(3):228-33. PubMed ID: 9249189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of adoptive transfer of murine Sjögren's syndrome into severe combined immunodeficient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1).
    Hayashi Y; Haneji N; Yanagi K; Higashiyama H; Yagita H; Hamano H
    Clin Exp Immunol; 1995 Nov; 102(2):360-7. PubMed ID: 7586691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-27 Regulated CD4
    Qi J; Zhang Z; Tang X; Li W; Chen W; Yao G
    Front Immunol; 2020; 11():1699. PubMed ID: 32849596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting EZH2 prevents the occurrence and mitigates the development of Sjögren's syndrome in mice.
    Zhu S; Liu M; Zhu F; Yu X; Wen J; Li C
    Int Immunopharmacol; 2022 Sep; 110():109073. PubMed ID: 35978516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren's syndrome.
    Zhou YB; Yuan X; Wang QK; Zhang H; Wang GS; Li XP; Wang Y; Harris D; Li XM
    Immunol Lett; 2020 Oct; 226():62-70. PubMed ID: 32707129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren's Syndrome.
    Fu J; Pu Y; Wang B; Li H; Yang X; Xie L; Shi H; Wang Z; Yin J; Zhan T; Shao Y; Chen C; Luo Q; Xu J; Zong Z; Wei X; Xiao W; Yu C; Zheng L
    J Immunol Res; 2022; 2022():3210200. PubMed ID: 35211629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of selectins (CD62 E,L,P) and cellular adhesion molecules in primary Sjögren's syndrome: questions to immunoregulation.
    Aziz KE; McCluskey PJ; Wakefield D
    Clin Immunol Immunopathol; 1996 Jul; 80(1):55-66. PubMed ID: 8674240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
    Baban B; Liu JY; Abdelsayed R; Mozaffari MS
    Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
    Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
    Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
    Voynova E; Lefebvre F; Qadri A; Muller S
    J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
    Wang X; Bootsma H; Terpstra J; Vissink A; van der Vegt B; Spijkervet FKL; Kroese FGM; Pringle S
    Rheumatology (Oxford); 2020 Oct; 59(10):3003-3013. PubMed ID: 32159757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cell adhesion molecules in tubulointerstitial nephritis associated with Sjögren's syndrome.
    Matsumura R; Umemiya K; Nakazawa T; Ochiai K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M
    Clin Nephrol; 1998 Feb; 49(2):74-81. PubMed ID: 9524776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
    Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ
    Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
    Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ
    Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
    Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
    Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
    Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.
    Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM
    Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.